Compare HCSG & TWST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | HCSG | TWST |
|---|---|---|
| Founded | 1976 | 2013 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Assisted Living Services | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.4B | 1.6B |
| IPO Year | N/A | 2018 |
| Metric | HCSG | TWST |
|---|---|---|
| Price | $19.10 | $31.13 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 5 | 9 |
| Target Price | $19.40 | ★ $46.33 |
| AVG Volume (30 Days) | 607.7K | ★ 1.8M |
| Earning Date | 10-22-2025 | 02-02-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.54 | N/A |
| Revenue | ★ $1,808,303,000.00 | $376,572,000.00 |
| Revenue This Year | $9.23 | $15.19 |
| Revenue Next Year | $5.55 | $15.10 |
| P/E Ratio | $35.86 | ★ N/A |
| Revenue Growth | 6.26 | ★ 20.32 |
| 52 Week Low | $9.13 | $23.30 |
| 52 Week High | $20.00 | $55.33 |
| Indicator | HCSG | TWST |
|---|---|---|
| Relative Strength Index (RSI) | 59.94 | 51.58 |
| Support Level | $17.96 | $31.19 |
| Resistance Level | $19.00 | $33.31 |
| Average True Range (ATR) | 0.51 | 1.58 |
| MACD | 0.03 | 0.06 |
| Stochastic Oscillator | 66.18 | 51.47 |
Healthcare Services Group Inc is a provider of housekeeping and facility management services to the healthcare industry. The company operates two business segments, both contributing roughly equally to the company's revenue: Housekeeping, laundry, linen, and other services; and Dietary department services. Housekeeping includes management of clients' housekeeping departments, cleaning, disinfecting and sanitizing, laundry, bed linen, and uniform services. Dietary consists of food purchasing, meal preparation, and providing dietitian consulting services. Its clients are nursing homes, retirement complexes, rehabilitation centers, and hospitals in the United States of America.
Twist Bioscience Corp is a synthetic biology company. It develops a disruptive DNA synthesis platform to industrialize the engineering of biology. The company's DNA synthesis platform utilizes a proprietary semiconductor-based synthetic DNA manufacturing process that synthesizes DNA on silicon instead of on traditional well-plastic plates to enable the production of high-quality synthetic DNA faster and affordable as well as overcomes inefficiencies and powers cost-effective, rapid high-throughput synthesis, enabling researchers to realize opportunities ahead rapidly. Geographically, it derives a majority of its revenue from the United States.